|
ZFP82 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9487099999993E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51530005104905E-09 |
| Normal-vs-Stage2 |
6.707700E-02 |
| Normal-vs-Stage3 |
1.314190E-01 |
| Normal-vs-Stage4 |
6.237200E-01 |
| Stage1-vs-Stage2 |
1.222410E-01 |
| Stage1-vs-Stage3 |
3.215400E-04 |
| Stage1-vs-Stage4 |
8.4010999999995E-05 |
| Stage2-vs-Stage3 |
3.865000E-01 |
| Stage2-vs-Stage4 |
1.695430E-01 |
| Stage3-vs-Stage4 |
4.315600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.06579999999512E-05 |
| Normal-vs-AfricanAmerican |
8.293700E-02 |
| Normal-vs-Asian |
1.614410E-01 |
| Caucasian-vs-AfricanAmerican |
5.011600E-01 |
| Caucasian-vs-Asian |
6.791600E-01 |
| AfricanAmerican-vs-Asian |
5.104200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.384400E-04 |
| Normal-vs-Female |
4.32320000000042E-05 |
| Male-vs-Female |
4.025200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.368850E-01 |
| Normal-vs-Age(41-60Yrs) |
1.14920000005014E-06 |
| Normal-vs-Age(61-80Yrs) |
2.199700E-03 |
| Normal-vs-Age(81-100Yrs) |
8.621400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.745200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.776000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.770990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.220400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.918100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.366430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.31479999998518E-07 |
| Normal-vs-Grade 2 |
3.73409969611771E-10 |
| Normal-vs-Grade 3 |
6.243900E-02 |
| Normal-vs-Grade 4 |
8.152600E-01 |
| Grade 1-vs-Grade 2 |
2.399400E-01 |
| Grade 1-vs-Grade 3 |
2.079100E-03 |
| Grade 1-vs-Grade 4 |
2.805900E-04 |
| Grade 2-vs-Grade 3 |
1.9036999999722E-06 |
| Grade 2-vs-Grade 4 |
1.29120000003091E-06 |
| Grade 3-vs-Grade 4 |
1.027980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.10130002287201E-09 |
| Normal-vs-ccB subtype |
2.737700E-02 |
| ccA subtype-vs-ccB subtype |
8.031400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.381200E-03 |
| Normal-vs-N1 |
5.327200E-01 |
| N0-vs-N1 |
9.721800E-02 |
|
|
